Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection

被引:0
|
作者
Wirth, Marielle [1 ,2 ,3 ]
Ruckes, Christian [4 ]
Michel, Maurice [5 ,6 ]
Schattenberg, Joern M. [5 ,6 ]
机构
[1] Heinrich Heine Univ, Univ Hosp Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Unit Hlth Serv Res,Med Fac, Dusseldorf, Germany
[2] Heinrich Heine Univ, Inst Biometr & Epidemiol, German Diabet Ctr DDZ, Leibniz Ctr Diabet Res, Dusseldorf, Germany
[3] German Ctr Diabet Res DZD, Munich Neuherberg, Germany
[4] Univ Med Ctr Mainz, Interdisciplinary Ctr Clin Studies, Mainz, Germany
[5] Univ Med Ctr Mainz, Dept Med 1, Metab Liver Res Program, Mainz, Germany
[6] Univ Med Ctr Mainz, Dept Med 1, Mainz, Germany
关键词
calibration; hepatic steatosis; HIV; risk prediction; validation; FATTY LIVER-DISEASE; CONTROLLED ATTENUATION PARAMETER; BODY-MASS INDEX; TRANSIENT ELASTOGRAPHY; VISCERAL FAT; PREVALENCE; STEATOHEPATITIS; DIAGNOSIS;
D O I
10.1097/QAD.0000000000003779
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
<bold>Objective: </bold>Early detection of hepatic steatosis in people with HIV (PWH) could prevent progression and inflammation. The aim was to develop and validate a multivariable risk prediction model for hepatic steatosis in German PWH. <bold>Design: </bold>In this cohort study, 282 PWH were prospectively enrolled, and hepatic steatosis was defined via controlled attenuation parameter (CAP; >= 275 dB/m) using vibration-controlled transient elastography. <bold>Methods: </bold>Three multivariable logistic regression models were conducted. Missing values were imputed with multiple imputation. Cut-offs were derived based on Youden-Indices. Performance was assessed via discriminatory and calibrative ability and accuracy via Brier Skill Score. Sensitivity, specificity, and predictive values were calculated. Internal validation was performed via bootstrapping. <bold>Results: </bold>The prevalence of hepatic steatosis was 35.3% (100/282). Univariate analyses revealed associations with age, waist circumference, BMI, hypertension, hyperlipidemia and gamma-gt. In multivariable analyses, male sex [odds ratio (OR) 2.07, 95% confidence interval (CI) 1.42-3.00, P = 0.001] and BMI (OR 1.27, 95% CI 1.18-1.36, P < 0.001) were identified as independent predictors of hepatic steatosis. The naive and optimism-corrected c -statistic of 79% showed a good discriminatory ability, the calibration was well with a slight tendency for overestimation for predicted probabilities above 70%. At the cutoff of 1.95, the specificity was 71% and the negative-predictive value 82.3%. Twenty-seven percent of the 282 patients would be misclassified, 17% as false positives and 10% as false negatives. <bold>Conclusion: </bold>The developed prediction model contributes to the lack of validated noninvasive tools to predict hepatic steatosis in people with HIV. Future studies should include more candidate predictors and externally validate the model.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 50 条
  • [1] Sex differences in the association of HIV infection with hepatic steatosis
    Kardashian, Ani
    Ma, Yifei
    Scherzer, Rebecca
    Price, Jennifer C.
    Sarkar, Monika
    Korn, Natalie
    Tillinghast, Kyle
    Peters, Marion G.
    Noworolski, Susan M.
    Tien, Phyllis C.
    AIDS, 2017, 31 (03) : 365 - 373
  • [2] Prevalence and predictors of hepatic steatosis among HIV patients with and without chronic hepatitis C
    Elsharkawy, Aisha
    Alem, Shereen Abdel
    Moustafa, Saeed
    Elnggar, Shymaa
    Cordie, Ahmed
    Esmat, Gamal
    Moustafa, Ahmed
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)
  • [3] Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication
    Chromy, David
    Mandorfer, Mattias
    Bucsics, Theresa
    Schwabl, Philipp
    Bauer, David
    Scheiner, Bernhard
    Schmidbauer, Caroline
    Lang, Gerold Felician
    Szekeres, Thomas
    Ferenci, Peter
    Trauner, Michael
    Reiberger, Thomas
    AIDS PATIENT CARE AND STDS, 2019, 33 (05) : 197 - 206
  • [4] Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma
    Li, Bo
    Zhao, Youyun
    Cai, Wangxi
    Ming, Anping
    Li, Hanmin
    CLINICAL PROTEOMICS, 2021, 18 (01)
  • [5] Development and validation of a multivariable risk prediction model for head and neck cancer using the UK Biobank
    McCarthy, Caroline Elizabeth
    Bonnet, Laura Jayne
    Marcus, Michael Williams
    Field, John K.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (05) : 1192 - 1202
  • [6] Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection
    Vecchi, Valentina Li
    Soresi, Maurizio
    Giannitrapani, Lydia
    Di Carlo, Paola
    Mazzola, Giovanni
    Colletti, Pietro
    Terranova, Antonino
    Vizzini, Giovanni
    Montalto, Giuseppe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (05) : E397 - E402
  • [7] Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis
    Long, Michelle T.
    Pedley, Alison
    Colantonio, Lisandro D.
    Massaro, Joseph M.
    Hoffmann, Udo
    Muntner, Paul
    Fox, Caroline S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (08) : 1172 - +
  • [8] The risk factors for hepatic steatosis in patients with primary aldosteronism
    Shibayama, Yui
    Wada, Norio
    Baba, Shuhei
    Obara, Shinji
    Sakai, Hidetsugu
    Usubuchi, Hiroaki
    Terae, Satoshi
    Nakamura, Akinobu
    Atsumi, Tatsuya
    ENDOCRINE JOURNAL, 2020, 67 (06) : 623 - 629
  • [9] Validation of Noninvasive Methods for Detecting Hepatic Steatosis in Patients With Human Immunodeficiency Virus Infection
    Siddiqui, M. Shadab
    Patidar, Kavish R.
    Boyett, Sherry
    Smith, Paula G.
    Sanyal, Arun J.
    Sterling, Richard K.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (02) : 402 - 405
  • [10] Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma
    Bo Li
    Youyun Zhao
    Wangxi Cai
    Anping Ming
    Hanmin Li
    Clinical Proteomics, 2021, 18